Journal of Cancer · 2016 · 23 citations · 48 references
According to these results, we suggest that 4-DACL may be a promising therapeutic agent for the treatment of malignant melanoma.
48
p21 is a universal inhibitor of cyclin kinases
Yue Xiong, Gregory J. Hannon, Hui Zhang et al. · Nature · 1993 · 3.4K citations
Receptor Tyrosine Kinase, Cyclin Kinases, Anti-cancer Agent +4
Patrick A. Baeuerle, David Baltimore · Cell · 1996 · 3K citations · Full text